documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

71 rows where docket_id = "FDA-1978-N-0027" and posted_year = 2003 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, posted_month, comment_start_date, comment_end_date, fr_doc_num, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

document_type 4

posted_year 1

  • 2003 · 71 ✖

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-1978-N-0027-0075 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Skin Protectant Drug Products for Over-the-Counter Human Use; Final Monograph; Technical Amendment Notice Notice of Final Rule 2003-12-09T05:00:00Z 2003 12 2003-12-09T05:00:00Z 2004-02-10T04:59:59Z 2019-08-01T14:04:49Z 03-30394 0 0 0900006480560e40
FDA-1978-N-0027-0074 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Acknowledgment Letter from FDA to Petition for Reconsideration from The Cosmetic, Toiletry & Fragrance Association Other Acknowledgement Letter/Receipt 2003-07-10T04:00:00Z 2003 7     2019-06-04T12:38:22Z   0 0 0900006480560e32
FDA-1978-N-0027-0073 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Acknowledgment Letter from FDA to Petition for Reconsideration from The Cosmetic, Toiletry & Fragrance Association Other Acknowledgement Letter/Receipt 2003-07-10T04:00:00Z 2003 7     2019-06-03T20:24:34Z   0 0 0900006480560e30
FDA-1978-N-0027-0069 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab I.9: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T14:55:09Z   0 0 0900006480560df8
FDA-1978-N-0027-0015 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab V.22: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:38:07Z   0 0 0900006480560cf8
FDA-1978-N-0027-0022 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab P.16: Letter from FDA to The United States Pharmacopeial Convention Inc. Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:39:02Z   0 0 0900006480560d0d
FDA-1978-N-0027-0036 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab B: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:41:02Z   0 0 0900006480560d3f
FDA-1978-N-0027-0059 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab Y: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:44:11Z   0 0 0900006480560ddc
FDA-1978-N-0027-0058 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab X: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:44:04Z   0 0 0900006480560dae
FDA-1978-N-0027-0072 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Skin Protectant Drug Products for Over The Counter Human Use; Final Notice Notice of Final Rule 2003-06-13T04:00:00Z 2003 6 2003-06-04T04:00:00Z 2003-09-03T03:59:59Z 2019-08-01T15:33:43Z 03-13751 0 0 0900006480560e22
FDA-1978-N-0027-0010 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab LL.38: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:37:23Z   0 0 0900006480560cf1
FDA-1978-N-0027-0012 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab S.19: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:37:41Z   0 0 0900006480560cf3
FDA-1978-N-0027-0019 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab Z.26: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:38:35Z   0 0 0900006480560d04
FDA-1978-N-0027-0024 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab BB.28: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:39:20Z   0 0 0900006480560d13
FDA-1978-N-0027-0025 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab CC.29: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:39:28Z   0 0 0900006480560d15
FDA-1978-N-0027-0037 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab C: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:41:10Z   0 0 0900006480560d41
FDA-1978-N-0027-0040 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab F: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:41:32Z   0 0 0900006480560d77
FDA-1978-N-0027-0042 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab H: Letter from FDA to Warner Lambert Company Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:41:48Z   0 0 0900006480560d7d
FDA-1978-N-0027-0046 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab L: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:42:21Z   0 0 0900006480560d89
FDA-1978-N-0027-0023 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab Q.17: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:39:12Z   0 0 0900006480560d10
FDA-1978-N-0027-0066 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab F.6: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:45:11Z   0 0 0900006480560def
FDA-1978-N-0027-0006 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab L.12: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:36:53Z   0 0 0900006480560ced
FDA-1978-N-0027-0020 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab AA.27: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:38:43Z   0 0 0900006480560d07
FDA-1978-N-0027-0033 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Table of Contents Re: Skin Protectant Drug Products for Over The Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:40:38Z   0 0 0900006480560d2b
FDA-1978-N-0027-0048 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab N: Letter of Acknowledgment from FDA to Revlon Health Care Group Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Rule Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:42:36Z   0 0 0900006480560d8f
FDA-1978-N-0027-0056 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab V: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:43:48Z   0 0 0900006480560da7
FDA-1978-N-0027-0014 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab U.21: Letter from FDA to Whitehall Laboratories Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:37:58Z   0 0 0900006480560cf5
FDA-1978-N-0027-0057 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab W: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:43:56Z   0 0 0900006480560daa
FDA-1978-N-0027-0008 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab N.14: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:37:13Z   0 0 0900006480560cef
FDA-1978-N-0027-0032 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab KK.37: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:40:29Z   0 0 0900006480560d28
FDA-1978-N-0027-0035 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab A: Subject- Citizen Petition on Aveeno Products Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:40:55Z   0 0 0900006480560d3d
FDA-1978-N-0027-0039 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab E: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:41:25Z   0 0 0900006480560d74
FDA-1978-N-0027-0049 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab O: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:42:44Z   0 0 0900006480560d91
FDA-1978-N-0027-0051 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab Q: Letter from Chesebrough Ponds Inc. to FDA Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:43:07Z   0 0 0900006480560d98
FDA-1978-N-0027-0028 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab GG.33: Letter from FDA to The United States PharmaCopeial Convention Inc. Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:39:52Z   0 0 0900006480560d1e
FDA-1978-N-0027-0053 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab S: Minutes of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:43:23Z   0 0 0900006480560da0
FDA-1978-N-0027-0017 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab X.24: Letter from FDA to The United States Pharmacopeial Convention Inc. Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-05T17:23:55Z   0 0 0900006480560cfd
FDA-1978-N-0027-0052 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab R: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:43:15Z   0 0 0900006480560d9b
FDA-1978-N-0027-0021 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab O.15: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:38:51Z   0 0 0900006480560d09
FDA-1978-N-0027-0045 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab K: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:42:12Z   0 0 0900006480560d86
FDA-1978-N-0027-0055 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab U: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:43:41Z   0 0 0900006480560da4
FDA-1978-N-0027-0061 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab A.1: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:44:27Z   0 0 0900006480560de2
FDA-1978-N-0027-0067 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab G.7: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:45:20Z   0 0 0900006480560df2
FDA-1978-N-0027-0005 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab K.11: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:36:41Z   0 0 0900006480560cec
FDA-1978-N-0027-0013 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab T.20: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:37:49Z   0 0 0900006480560cf4
FDA-1978-N-0027-0031 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab JJ.36: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:40:20Z   0 0 0900006480560d26
FDA-1978-N-0027-0034 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab 1.0: Correspondence & Memoranda Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:40:46Z   0 0 0900006480560d3a
FDA-1978-N-0027-0044 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab J: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:42:04Z   0 0 0900006480560d82
FDA-1978-N-0027-0062 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab B.2: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:44:39Z   0 0 0900006480560de5
FDA-1978-N-0027-0011 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab R.18: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:37:31Z   0 0 0900006480560cf2
FDA-1978-N-0027-0016 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab W.23: Letter from FDA to Joseph Deutsch Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:38:14Z   0 0 0900006480560cfc
FDA-1978-N-0027-0026 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab EE.31: Letter from FDA to David Buddrus M.D. Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:39:36Z   0 0 0900006480560d18
FDA-1978-N-0027-0030 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab II.35: Letter from FDA to The Andrews Jergens Company Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:40:09Z   0 0 0900006480560d23
FDA-1978-N-0027-0038 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab D: Letter from FDA to Church and Dwight Co., Inc. Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:41:18Z   0 0 0900006480560d70
FDA-1978-N-0027-0071 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Skin Protectant Drug Products for Over The Counter Human Use; Final Notice Notice of Final Rule 2003-06-13T04:00:00Z 2003 6 2003-06-04T04:00:00Z 2003-09-03T03:59:59Z 2019-08-01T15:28:54Z 03-13751 0 0 0900006480560e1d
FDA-1978-N-0027-0007 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab M.13: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:37:00Z   0 0 0900006480560cee
FDA-1978-N-0027-0018 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab Y.25: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:38:27Z   0 0 0900006480560d01
FDA-1978-N-0027-0041 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab G: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:41:41Z   0 0 0900006480560d7a
FDA-1978-N-0027-0060 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab Z: Memo Record of Lubriderm Drug Labeling Claim Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:44:19Z   0 0 0900006480560de0
FDA-1978-N-0027-0027 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab FF.32: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:39:43Z   0 0 0900006480560d1b
FDA-1978-N-0027-0047 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab M: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:42:28Z   0 0 0900006480560d8b
FDA-1978-N-0027-0050 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab P: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:43:00Z   0 0 0900006480560d93
FDA-1978-N-0027-0065 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab E.5: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:45:02Z   0 0 0900006480560dee
FDA-1978-N-0027-0068 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab H.8: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:45:28Z   0 0 0900006480560df6
FDA-1978-N-0027-0064 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab D.4: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:44:53Z   0 0 0900006480560deb
FDA-1978-N-0027-0029 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab HH.34: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:40:01Z   0 0 0900006480560d21
FDA-1978-N-0027-0043 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab I: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:41:55Z   0 0 0900006480560d80
FDA-1978-N-0027-0054 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab T: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:43:30Z   0 0 0900006480560da1
FDA-1978-N-0027-0063 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab C.3: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:44:46Z   0 0 0900006480560de8
FDA-1978-N-0027-0070 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab J.10: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-06T15:45:40Z   0 0 0900006480560e1a
FDA-1978-N-0027-0009 FDA Skin Protectant Drugs for O. T. C. Human Use FDA-1978-N-0027 Tab DD.30: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph Supporting & Related Material Background Material 2003-06-13T04:00:00Z 2003 6     2019-06-05T17:22:38Z   0 0 0900006480560cf0

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);